NCT00486694View on ClinicalTrials.gov

Artesunate Plus Sulfadoxine-Pyrimethamine Versus Chloroquine for Vivax Malaria

PHASE2CompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

August 31, 2004

Conditions
Malaria, Vivax
Interventions
DRUG

Sulfadoxine-pyrimethamine + artesunate

DRUG

Chloroquine

All Listed Sponsors
lead

London School of Hygiene and Tropical Medicine

OTHER

NCT00486694 - Artesunate Plus Sulfadoxine-Pyrimethamine Versus Chloroquine for Vivax Malaria | Biotech Hunter | Biotech Hunter